Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05119335
Title A Study of NKT2152, a HIF2a Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NiKang Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth RECRUITING Scottsdale Arizona 85258 United States Details
UCLA RECRUITING Los Angeles California 90095 United States Details
Sarah Cannon Research Institute RECRUITING Denver Colorado 80218 United States Details
Emory University RECRUITING Atlanta Georgia 30322 United States Details
Indiana University Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
University of Iowa RECRUITING Iowa City Iowa 52242 United States Details
National Cancer Institute RECRUITING Bethesda Maryland 20892-9760 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
University of Oklahoma ACTIVE_NOT_RECRUITING Oklahoma City Oklahoma 73117 United States Details
Oregon Health and Science University RECRUITING Portland Oregon 97239 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Seattle Cancer Care Alliance RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field